TwinStrand DuplexSeq measuring MRD in AML

Legal Notices – Patents

Last modified: August 2, 2021

This page is intended to serve as notice under 35 U.S.C. § 287(a) that TwinStrand products and services, including but not limited to TwinStrand Duplex Sequencing™ Kits, the TwinStrand DuplexSeq™ Bioinformatics Platform, and/or methods of using the foregoing, may be covered by one or more of the following U.S. patent(s), which are owned by or exclusively licensed to TwinStrand Biosciences, Inc. (“TwinStrand”):

U.S. Patent Numbers:

US 9,752,188
US 10,287,631
US 10,370,713
US 10,385,393
US 10,570,451
US 9,970,054
US 10,604,804
US 10,689,699
US 10,689,700
US 10,711,304
US 10,752,951
US 10,760,127
US 10,870,882
US 11,047,006

Foreign Patent Numbers:

EP 2828218
EP 2855707
CA 2,872,141
AU 2013267609

Additional patents pending in the U.S. and in several foreign jurisdictions.